S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e60614fc-n/a
Main Authors: Jacobs, Ryan, Nair, Ranjit, Cho, Seok‐Goo, Devata, Sumana, Gaballa, Sameh, Yoon, Dok Hyun, Stevens, Don, Kim, Jin Seok, Shah, Nirav N, Brennan, Denise Marie, Law, Jason, Lesley, Robin, Chen, Rob, Forcina, Alessandra, Buelow, Ben, Hou, Jing‐Zhou
Format: Article
Language:English
Subjects:
Oral Sessions
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S3
container_start_page e60614fc
container_title HemaSphere
container_volume 7
creator Jacobs, Ryan
Nair, Ranjit
Cho, Seok‐Goo
Devata, Sumana
Gaballa, Sameh
Yoon, Dok Hyun
Stevens, Don
Kim, Jin Seok
Shah, Nirav N
Brennan, Denise Marie
Law, Jason
Lesley, Robin
Chen, Rob
Forcina, Alessandra
Buelow, Ben
Hou, Jing‐Zhou
description
doi_str_mv 10.1097/01.HS9.0000967808.60614.fc
format article
fullrecord <record><control><sourceid>wiley_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_89b6f6d3e96a4eb59ded576b91f97b35</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_89b6f6d3e96a4eb59ded576b91f97b35</doaj_id><sourcerecordid>HEM3BF06299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2859-e7051bab39834172240f1d7812f0b626aa6c2ca96a7531a7779a0fb43e0074543</originalsourceid><addsrcrecordid>eNqVks1u1DAQxyMEElXpO1icu1vbcex4LyjNOh-S86EkC-zJchKnpNo2VVJAvfEIPAkPxZPgdhHQI3PxjGf-P3ukv-O8RXCNIGcXEK2Tmq-hDU6ZD_01hRSR9dC9cE6wx_CKY4Je_pO_ds6W5drOI845xezE-VFjTDYgSeMEhEVWStEIUIm6LPLaJoGtPqRNApr88ue378Sn5yAAefFeSBBuEf8Ybl3Q2E4opAQij4NYVOcgzS1DBmUttheViKogbIpqD6JCyjTcyaACcp-VSZEFGzvbiCrNHh_dyaYGUVVkIMhBkcdFmsegTAL7EwTqZrfdv3FeDfqwmLPf56mzi0QTJitZxGkYyFWHfY-vDIMeanXrct8liNkV4YB65iM8wJZiqjXtcKc51cxzkWaMcQ2HlrgGQkY84p466ZHbT_pa3c3jjZ4f1KRH9XQxzVdKz_djdzDK5y0daO8aSyOm9Xhveo_RlqOBs9b1LOvdkXX3ub0xfWdu72d9eAZ93rkdP6mr6YtCkGCfYG4JmyOhm6dlmc3wR4ygerSCgkhZK6i_VlBPVlBDZ8XhUfx1PJiH_1CqRGTuZQQp5tz9Bbwdr7E</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY</title><source>Wiley Open Access</source><source>PubMed Central</source><creator>Jacobs, Ryan ; Nair, Ranjit ; Cho, Seok‐Goo ; Devata, Sumana ; Gaballa, Sameh ; Yoon, Dok Hyun ; Stevens, Don ; Kim, Jin Seok ; Shah, Nirav N ; Brennan, Denise Marie ; Law, Jason ; Lesley, Robin ; Chen, Rob ; Forcina, Alessandra ; Buelow, Ben ; Hou, Jing‐Zhou</creator><creatorcontrib>Jacobs, Ryan ; Nair, Ranjit ; Cho, Seok‐Goo ; Devata, Sumana ; Gaballa, Sameh ; Yoon, Dok Hyun ; Stevens, Don ; Kim, Jin Seok ; Shah, Nirav N ; Brennan, Denise Marie ; Law, Jason ; Lesley, Robin ; Chen, Rob ; Forcina, Alessandra ; Buelow, Ben ; Hou, Jing‐Zhou</creatorcontrib><identifier>ISSN: 2572-9241</identifier><identifier>EISSN: 2572-9241</identifier><identifier>DOI: 10.1097/01.HS9.0000967808.60614.fc</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins</publisher><subject>Oral Sessions</subject><ispartof>HemaSphere, 2023-08, Vol.7 (S3), p.e60614fc-n/a</ispartof><rights>Copyright © 2023 The Author(s).</rights><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428429/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428429/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,11543,27905,27906,46033,46457,53772,53774</link.rule.ids></links><search><creatorcontrib>Jacobs, Ryan</creatorcontrib><creatorcontrib>Nair, Ranjit</creatorcontrib><creatorcontrib>Cho, Seok‐Goo</creatorcontrib><creatorcontrib>Devata, Sumana</creatorcontrib><creatorcontrib>Gaballa, Sameh</creatorcontrib><creatorcontrib>Yoon, Dok Hyun</creatorcontrib><creatorcontrib>Stevens, Don</creatorcontrib><creatorcontrib>Kim, Jin Seok</creatorcontrib><creatorcontrib>Shah, Nirav N</creatorcontrib><creatorcontrib>Brennan, Denise Marie</creatorcontrib><creatorcontrib>Law, Jason</creatorcontrib><creatorcontrib>Lesley, Robin</creatorcontrib><creatorcontrib>Chen, Rob</creatorcontrib><creatorcontrib>Forcina, Alessandra</creatorcontrib><creatorcontrib>Buelow, Ben</creatorcontrib><creatorcontrib>Hou, Jing‐Zhou</creatorcontrib><title>S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY</title><title>HemaSphere</title><subject>Oral Sessions</subject><issn>2572-9241</issn><issn>2572-9241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqVks1u1DAQxyMEElXpO1icu1vbcex4LyjNOh-S86EkC-zJchKnpNo2VVJAvfEIPAkPxZPgdhHQI3PxjGf-P3ukv-O8RXCNIGcXEK2Tmq-hDU6ZD_01hRSR9dC9cE6wx_CKY4Je_pO_ds6W5drOI845xezE-VFjTDYgSeMEhEVWStEIUIm6LPLaJoGtPqRNApr88ue378Sn5yAAefFeSBBuEf8Ybl3Q2E4opAQij4NYVOcgzS1DBmUttheViKogbIpqD6JCyjTcyaACcp-VSZEFGzvbiCrNHh_dyaYGUVVkIMhBkcdFmsegTAL7EwTqZrfdv3FeDfqwmLPf56mzi0QTJitZxGkYyFWHfY-vDIMeanXrct8liNkV4YB65iM8wJZiqjXtcKc51cxzkWaMcQ2HlrgGQkY84p466ZHbT_pa3c3jjZ4f1KRH9XQxzVdKz_djdzDK5y0daO8aSyOm9Xhveo_RlqOBs9b1LOvdkXX3ub0xfWdu72d9eAZ93rkdP6mr6YtCkGCfYG4JmyOhm6dlmc3wR4ygerSCgkhZK6i_VlBPVlBDZ8XhUfx1PJiH_1CqRGTuZQQp5tz9Bbwdr7E</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>Jacobs, Ryan</creator><creator>Nair, Ranjit</creator><creator>Cho, Seok‐Goo</creator><creator>Devata, Sumana</creator><creator>Gaballa, Sameh</creator><creator>Yoon, Dok Hyun</creator><creator>Stevens, Don</creator><creator>Kim, Jin Seok</creator><creator>Shah, Nirav N</creator><creator>Brennan, Denise Marie</creator><creator>Law, Jason</creator><creator>Lesley, Robin</creator><creator>Chen, Rob</creator><creator>Forcina, Alessandra</creator><creator>Buelow, Ben</creator><creator>Hou, Jing‐Zhou</creator><general>Lippincott Williams &amp; Wilkins</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230808</creationdate><title>S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY</title><author>Jacobs, Ryan ; Nair, Ranjit ; Cho, Seok‐Goo ; Devata, Sumana ; Gaballa, Sameh ; Yoon, Dok Hyun ; Stevens, Don ; Kim, Jin Seok ; Shah, Nirav N ; Brennan, Denise Marie ; Law, Jason ; Lesley, Robin ; Chen, Rob ; Forcina, Alessandra ; Buelow, Ben ; Hou, Jing‐Zhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2859-e7051bab39834172240f1d7812f0b626aa6c2ca96a7531a7779a0fb43e0074543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Oral Sessions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobs, Ryan</creatorcontrib><creatorcontrib>Nair, Ranjit</creatorcontrib><creatorcontrib>Cho, Seok‐Goo</creatorcontrib><creatorcontrib>Devata, Sumana</creatorcontrib><creatorcontrib>Gaballa, Sameh</creatorcontrib><creatorcontrib>Yoon, Dok Hyun</creatorcontrib><creatorcontrib>Stevens, Don</creatorcontrib><creatorcontrib>Kim, Jin Seok</creatorcontrib><creatorcontrib>Shah, Nirav N</creatorcontrib><creatorcontrib>Brennan, Denise Marie</creatorcontrib><creatorcontrib>Law, Jason</creatorcontrib><creatorcontrib>Lesley, Robin</creatorcontrib><creatorcontrib>Chen, Rob</creatorcontrib><creatorcontrib>Forcina, Alessandra</creatorcontrib><creatorcontrib>Buelow, Ben</creatorcontrib><creatorcontrib>Hou, Jing‐Zhou</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>HemaSphere</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacobs, Ryan</au><au>Nair, Ranjit</au><au>Cho, Seok‐Goo</au><au>Devata, Sumana</au><au>Gaballa, Sameh</au><au>Yoon, Dok Hyun</au><au>Stevens, Don</au><au>Kim, Jin Seok</au><au>Shah, Nirav N</au><au>Brennan, Denise Marie</au><au>Law, Jason</au><au>Lesley, Robin</au><au>Chen, Rob</au><au>Forcina, Alessandra</au><au>Buelow, Ben</au><au>Hou, Jing‐Zhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY</atitle><jtitle>HemaSphere</jtitle><date>2023-08-08</date><risdate>2023</risdate><volume>7</volume><issue>S3</issue><spage>e60614fc</spage><epage>n/a</epage><pages>e60614fc-n/a</pages><issn>2572-9241</issn><eissn>2572-9241</eissn><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1097/01.HS9.0000967808.60614.fc</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2572-9241
ispartof HemaSphere, 2023-08, Vol.7 (S3), p.e60614fc-n/a
issn 2572-9241
2572-9241
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_89b6f6d3e96a4eb59ded576b91f97b35
source Wiley Open Access; PubMed Central
subjects Oral Sessions
title S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S224:%20HIGH%20COMPLETE%20RESPONSE%20RATE%20WITH%20TNB%E2%80%90486,%20A%20NOVEL%20CD19XCD3%20T%E2%80%90CELL%20ENGAGER,%20IN%20RELAPSED/REFRACTORY%20FOLLICULAR%20LYMPHOMA:%20INTERIM%20RESULTS%20FROM%20AN%20ONGOING%20PHASE%201%20STUDY&rft.jtitle=HemaSphere&rft.au=Jacobs,%20Ryan&rft.date=2023-08-08&rft.volume=7&rft.issue=S3&rft.spage=e60614fc&rft.epage=n/a&rft.pages=e60614fc-n/a&rft.issn=2572-9241&rft.eissn=2572-9241&rft_id=info:doi/10.1097/01.HS9.0000967808.60614.fc&rft_dat=%3Cwiley_doaj_%3EHEM3BF06299%3C/wiley_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2859-e7051bab39834172240f1d7812f0b626aa6c2ca96a7531a7779a0fb43e0074543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true